These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7730142)

  • 1. Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma.
    Fujimoto K; Ichimori Y; Yamaguchi H; Arai K; Futami T; Ozono S; Hirao Y; Kakizoe T; Terada M; Okajima E
    Jpn J Cancer Res; 1995 Feb; 86(2):182-6. PubMed ID: 7730142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma.
    Fujimoto K; Ichimori Y; Kakizoe T; Okajima E; Sakamoto H; Sugimura T; Terada M
    Biochem Biophys Res Commun; 1991 Oct; 180(1):386-92. PubMed ID: 1718278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma.
    Rasmuson T; Grankvist K; Jacobsen J; Ljungberg B
    Eur J Cancer; 2001 Nov; 37(17):2199-203. PubMed ID: 11677107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ferritin: a tumor marker for renal cell carcinoma.
    Essen A; Ozen H; Ayhan A; Ergen A; Tasar C; Remzi F
    J Urol; 1991 Jun; 145(6):1134-7. PubMed ID: 2033679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomas.
    Edgren M; Lennernäs B; Larsson A; Nilsson S
    Anticancer Res; 1999; 19(1B):869-73. PubMed ID: 10216508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
    Edgren M; Lennernäs B; Larsson A; Kälkner KM
    Anticancer Res; 2001; 21(2B):1423-9. PubMed ID: 11396226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
    Horstmann M; Merseburger AS; von der Heyde E; Serth J; Wegener G; Mengel M; Feil G; Hennenlotter J; Nagele U; Anastasiadis A; Bokemeyer C; Stenzl A; Kuczyk M
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):715-22. PubMed ID: 16080018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Messenger ribonucleic acids for fibroblast growth factors and their receptor in bladder and renal cell carcinoma cell lines.
    Yoshimura K; Eto H; Miyake H; Hara I; Arakawa S; Kamidono S
    Cancer Lett; 1996 May; 103(1):91-7. PubMed ID: 8616814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume.
    Partin AW; Criley SR; Steiner MS; Hsieh K; Simons JW; Lumadue J; Carter HB; Marshall FF
    Urology; 1995 Feb; 45(2):211-7. PubMed ID: 7855968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patients.
    Porta C; Paglino C; Imarisio I; Ganini C; Sacchi L; Quaglini S; Giunta V; De Amici M
    Oncology; 2013; 84(2):115-22. PubMed ID: 23154434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor (FGF-2) in renal cell carcinoma, which is indistinguishable from that in normal kidney, is involved in renal cell carcinoma growth.
    Emoto N; Isozaki O; Ohmura E; Ito F; Tsushima T; Shizume K; Demura H; Toma H
    J Urol; 1994 Nov; 152(5 Pt 1):1626-31. PubMed ID: 7523715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.
    Guðbrandsdottir G; Hjelle KM; Frugård J; Bostad L; Aarstad HJ; Beisland C
    Scand J Urol; 2015; 49(5):388-94. PubMed ID: 25773545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tissue factor as a biomarker for renal clear cell carcinoma.
    Silva DD; Noronha JAP; Pinheiro da Costa BE; Zandona PCE; Carvalhal GF
    Int Braz J Urol; 2018; 44(1):38-44. PubMed ID: 28727370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma.
    Alamdari FI; Rasmuson T; Grankvist K; Ljungberg B
    Scand J Urol Nephrol; 2007; 41(1):5-9. PubMed ID: 17366095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
    Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF; Wood CG; Karam JA
    J Urol; 2017 Aug; 198(2):281-288. PubMed ID: 28268170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume.
    Kirkali Z; Güzelsoy M; Mungan MU; Kirkali G; Yörükoglu K
    Urol Int; 1999; 62(1):21-5. PubMed ID: 10436426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.
    Vom Dorp F; Tschirdewahn S; Niedworok C; Reis H; Krause H; Kempkensteffen C; Busch J; Kramer G; Shariat SF; Nyirady P; Rübben H; Szarvas T
    J Urol; 2016 Apr; 195(4 Pt 1):1120-5. PubMed ID: 26454102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
    Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.